Search for: "Does 1 - 35" Results 621 - 640 of 9,760
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 May 2023, 9:43 am by Rose Hughes
The granted claims were directed to antibodies capable of 1) binding to a specific epitope on PCSK9, and 2) blocking the activity of PCSK9. [read post]
30 May 2023, 9:05 pm by renholding
Overall, our results suggest that firms’ gender diversity does not seem to correlate with the decision to publicly release its EEO-1 form. [read post]
30 May 2023, 9:01 pm by Leslie C. Griffin
” (35) The report repeatedly tells us, “the consequences of child sex abuse do not end when the abuse ends. [read post]
30 May 2023, 8:47 am by David Strifling
Chicago will supply treated Lake Michigan water to Joliet for a century, beginning in 2030, at a cost estimated to approach $1 billion in today’s dollars. [read post]
28 May 2023, 4:00 am by Administrator
The result is that the net delay of about 35 months is an unreasonable delay contrary to s. [read post]
27 May 2023, 5:50 pm
(Ethics Council Recommendation p. 13).)The Council identified the following threats: (1) Dust generated by truck traffic; (2) vibration; (3) visitor impacts; (4) increased humidity (including those generated by Tonasa's activities and the activity of local farmers; (5) and the possibility of loss of undiscovered art. [read post]
24 May 2023, 9:17 am by Rob Robinson
While ComplexDiscovery regularly highlights this information, it does not assume any responsibility for content assertions. [read post]
24 May 2023, 3:22 am by Thalia Kruger
This is an aspect that has been uniformly established by the EU legislator, thus it does not depend on national law (Article 46(1)). [read post]
23 May 2023, 2:57 pm by centerforartlaw
At nearly 94 years of age, Kusama is widely acknowledged as one of the most accomplished living artists.[1] Renowned globally, she possesses a distinctive and captivating visual style that has mesmerized audiences. [read post]
22 May 2023, 4:59 pm by Nathan Lee and Daniel Yannuzzi
After a nine-year saga, beginning when Amgen sued Sanofi for allegedly infringing two of its patents in 2014, the Supreme Court held that Amgen’s asserted patents failed to satisfy the enablement requirement under 35 U.S.C. [read post]